A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2106 participants

Study Classification

OBSERVATIONAL

Study Start Date

2003-01-31

Study Completion Date

2003-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients with Parkinson's disease will be seen by a dermatologist who will biopsy any suspicious skin lesions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson's Disease Malignant Melanoma

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Observational procedure

Patients will be examined and any suspicious skin abnormalities will be biopsied

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Confirmed diagnosis Parkinson's disease Patient able and willing to give informed consent Patient must not be taking any investigational drug at the time of enrollment

Exclusion Criteria

unconfirmed, undocumented Parkinson's disease unable to give consent taking any investigational product

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Teva Neuroscience

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bruce Schwartz, Ph.D.

Role: STUDY_DIRECTOR

Teva Neuroscience, Inc.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EP002

Identifier Type: -

Identifier Source: org_study_id